HK
Harleen Kaur Bhatia
About Harleen Kaur Bhatia
Data last updated:
Harleen Kaur Bhatia is a Director at Unimarck Pharma (India) Limited (since 2023) and Director at Teriot Pharmaceuticals Private Limited (since 2016). The companies operate in Pharma. The largest current company by reported revenue is Unimarck Pharma (India) Limited at ₹58.24 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Unimarck Pharma (India) Limited U24232CH1984PLC005768 | Director | 01 Apr 2023 | 1984 | ₹58.24 Cr (FY 2025) | Active |
 Teriot Pharmaceuticals Private Limited U51397PB2000PTC023355 | Director | 23 Jan 2016 | 2000 | Active |
Board colleagues of Harleen Kaur Bhatia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gagandeep Bhatia | 00660772 | Unimarck Pharma (India) Limited | Whole-Time Director |
| Harsh Bhatia | 00659651 | Unimarck Pharma (India) Limited | Whole-Time Director |
| Mandeep Singh | 01893488 | Unimarck Pharma (India) Limited , Teriot Pharmaceuticals Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Harleen Kaur Bhatia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harleen Kaur Bhatia
Harleen Kaur Bhatia currently holds 2 directorships: Unimarck Pharma (India) Limited (Director, since 01 Apr 2023, revenue ₹58.24 Cr (FY 2025)); Teriot Pharmaceuticals Private Limited (Director, since 23 Jan 2016).
Harleen Kaur Bhatia was first appointed on 23 Jan 2016 as Director at Teriot Pharmaceuticals Private Limited. The most recent appointment on record is 01 Apr 2023 at Unimarck Pharma (India) Limited.
The current boards of Harleen Kaur Bhatia's companies include Gagandeep Bhatia (Unimarck Pharma (India) Limited), Harsh Bhatia (Unimarck Pharma (India) Limited), Mandeep Singh (Unimarck Pharma (India) Limited).